- Academic Registry
Programme & Unit Catalogues


PA40157: The molecular biology and treatment of cancer

[Page last updated: 15 October 2020]

Follow this link for further information on academic years Academic Year: 2020/1
Further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Further information on credits Credits: 6      [equivalent to 12 CATS credits]
Further information on notional study hours Notional Study Hours: 120
Further information on unit levels Level: Masters UG & PG (FHEQ level 7)
Further information on teaching periods Period:
Semester 2
Further information on unit assessment Assessment Summary: EX 100%
Further information on unit assessment Assessment Detail:
  • Examination (EX 100%)
Further information on supplementary assessment Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites:
Description: Aims:
To familiarise the student with recent advances in molecular and cellular processes underlying tumour development and its treatment.

Learning Outcomes:
On successful completion of this unit, the student should be able to demonstrate an in-depth knowledge and understanding of the disease process in cancer and the complexity of its treatment, to evaluate critically this knowledge in order to resolve conflicting issues and thus identify and analyse rational treatment protocols.

Skills:
Scientific skills (T/F/A)
Study skills, handling information, working with others (T/F)
Problem solving (T/F)

Content:
Epidemiological studies of cancer and a recognition of how this approach retains validity. Chemical mutagenesis. Cell biology of tumour development including apoptosis, oncogenes and tumour suppressor genes. The molecular mechanisms of action of the major classes of drugs currently in use and their shortcomings. Active and passive immunotherapy. Then either the clinical or research setting; palliative or curative treatment, relationship to surgery, chemotherapy or radiotherapy, risk-benefit analysis. CRM Guidelines on safe handling of cytotoxic agents.
Further information on programme availabilityProgramme availability:

PA40157 is Optional on the following programmes:

Department of Pharmacy & Pharmacology Programmes in Natural Sciences
  • UXXX-AFM01 : MSci(Hons) Natural Sciences (Biochemistry with Pharmacology stream) (Year 4)
  • UXXX-AAM02 : MSci(Hons) Natural Sciences (Biochemistry with Pharmacology stream) with Study year abroad (Year 5)
  • UXXX-AKM02 : MSci(Hons) Natural Sciences (Biochemistry with Pharmacology stream) with Professional Placement (Year 5)
  • UXXX-AFM01 : MSci(Hons) Natural Sciences (Biology with Pharmacology stream) (Year 4)
  • UXXX-AAM02 : MSci(Hons) Natural Sciences (Biology with Pharmacology stream) with Study year abroad (Year 5)
  • UXXX-AKM02 : MSci(Hons) Natural Sciences (Biology with Pharmacology stream) with Professional Placement (Year 5)
  • UXXX-AFM01 : MSci(Hons) Natural Sciences (Chemistry with Pharmacology stream) (Year 4)
  • UXXX-AAM02 : MSci(Hons) Natural Sciences (Chemistry with Pharmacology stream) with Study year abroad (Year 5)
  • UXXX-AKM02 : MSci(Hons) Natural Sciences (Chemistry with Pharmacology stream) with Professional Placement (Year 5)

Notes: